A major meta-analysis of fibrate drugs has shown they modestly reduce the risk of major cardiovascular events, mainly through prevention of coronary artery disease and the need for revascularization.
The use of certain psychotropic medications may enhance an already high underlying risk for osteoporosis, Canadian investigators reported at the meeting here.
